Brief: Harpoon Therapeutics And Roche To Collaborate On Clinical Trials To Study Novel Immuno-Oncology Combination For Small Cell Lung Cancer
02/05/2022 14:18
May 2 (Reuters) - Harpoon Therapeutics Inc HARP.O :
* HARPOON THERAPEUTICS AND ROCHE TO COLLABORATE ON CLINICAL
TRIALS
TO STUDY NOVEL IMMUNO-ONCOLOGY COMBINATION FOR SMALL CELL LUNG
CANCER
* HARPOON THERAPEUTICS INC - UNDER THIS AGREEMENT, CO IS
SPONSOR
OF ANTICIPATED CLINICAL TRIALS, AND ROCHE WILL SUPPLY
ATEZOLIZUMAB
Source text for Eikon: ID:nGNX2zNw7Z
Further company coverage: HARP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Harpoon Therapeutics
See all newsBrief: Harpoon Therapeutics Receives 17 Additional Demands Seeking Disclosures in Proxy Statement
U.S. RESEARCH ROUNDUP-Axonics, BlackRock, Credit Acceptance
U.S. STOCKS ON THE MOVE-Core & Main, Commercial Metals, Equifax
U.S. STOCKS ON THE MOVE-Toll Brothers, American Eagle Outfitters, Twilio
Wrapup 1: Drugmakers kick off industry conference with two cancer deals